Waypoint Bio
9 known investors
Waypoint Bio uses artificial intelligence, computer vision, and pooled screening to conduct deep phenotyping across thousands of cell therapy designs, enabling the discovery and optimization of superior cell therapy candidates for development.
AI & Machine LearningBiotechDeep Tech
Founders & leadership
XW
Xinchen Wang, Ph.D.Co-founder & CEO
DP
David Phizicky, Ph.D.Co-founder & CSO
XW
Xinchen WanginCo-founder and CEO
Investors · 9
Amplify PartnersMenlo Park · $500K – $5M
Fifty YearsSan Francisco · $250K – $2M
Hummingbird VenturesSingapore · $500K – $10M
MBX CapitalClaymont · $250K – $2.5M
Mitsui Global InvestmentMenlo Park · $500K – $10M
Recode VenturesSan Franciscovia Armen A. Vidian · inferred
Amplify Partners CVreportedMenlo Park
.png)
General CatalystreportedSan Francisco · $30M
Lux CapitalreportedNew York · $100K – $100M
Funding
SEC filings, press & company announcements- Undisclosed amountSeries AJun 2026 · 2 sources
Amplify Partners (lead)
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Competitors · 3
by search overlapAskBio14 shared keywordsAskBio develops gene therapies based on adeno-associated virus (AAV) technology, with a clinical pipeline targeting central nervous system, neuromuscular, metabolic, and cardiovascular disorders. Founded in 2001 and operating as a subsidiary of Bayer AG, the company runs research and in-house AAV manufacturing across the US and Europe.
Bridgebio13 shared keywordsBridgeBio develops treatments for genetic conditions and cancers using a decentralized hub-and-spoke model, where autonomous teams focus on specific diseases or drug candidates while a central hub provides clinical, regulatory, and commercial support. The company partners with academic institutions to advance early-stage research toward late-stage clinical trials.
bio10 shared keywordsThe Biotechnology Innovation Organization (BIO) is an advocacy organization representing biotech companies, industry leaders, and state biotech associations across the United States and more than 35 countries. It provides members with policy advocacy, cost-saving programs, educational webinars, and organizes the BIO International Convention and other industry conferences.
Companies competing with Waypoint Bio for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Waypoint Bio do?
- Waypoint Bio uses artificial intelligence, computer vision, and pooled screening to conduct deep phenotyping across thousands of cell therapy designs, enabling the discovery and optimization of superior cell therapy candidates for development.
- Who founded Waypoint Bio?
- Waypoint Bio was founded by Xinchen Wang, Ph.D., David Phizicky, Ph.D., Xinchen Wang.
- Who are Waypoint Bio's investors?
- Waypoint Bio's investors include Amplify Partners, Fifty Years, Hummingbird Ventures, MBX Capital, Mitsui Global Investment, Recode Ventures, Amplify Partners CV, General Catalyst and 1 more.